Americans Are Dangerously Dependent on Foreign-made Generic Drugs. Tariffs Can Fix That.
Tariffs on pharmaceutical companies isn’t just good economic policy — it benefits national security and public health.
America’s Generic Drug Crisis Demands Investment, Not Dependence
The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.
What the National Institutes of Health Does for the Economy and the Health of Our Citizens
The National Institutes of Health (NIH) is today the main source of new drugs in this country – indeed the world, because America leads in the field. It has a critical importance to America’s health. Less well known is its huge, positive, economic impact.
Drug Safety Concerns: Four Indian Pharma Companies Issue Recalls in Last Three Months
It’s been a rough start to 2025 for Indian pharmaceutical giants. Four of India’s biggest generic drug producers issued product recalls in the last three months.
CPA Highlights Critical Role of NSF and NIH in Driving U.S. Innovation and Industrial Leadership
Strong federal investment in the National Science Foundation and National Institutes of Health is vital for American innovation, economic growth, and national security.
China Drug Exports to U.S. Rise as America Reaches a Crossroads in Its Own Supply Shortfalls
In 2024, China and India accounted for 57.6% of total U.S. pharmaceutical imports by weight, highlighting the potential risks associated with such reliance. Growing U.S. dependence on China and India for widely-used generic pharmaceutical products creates serious risks to national security and patient safety when drugs are in short supply, or ineffective.
CPA Announces Leadership Changes as CEO Michael Stumo Joins Trump Administration
CPA announced key leadership changes as CEO Michael Stumo steps down to take on a new role in the Trump administration. Jon Toomey has been elevated as President of CPA to lead the organization and Nick Iacovella has been promoted to Executive Vice President.
CPA Applauds Robert F. Kennedy, Jr’s Confirmation as HHS Secretary
For far too long, America has been at the mercy of foreign producers that routinely violate FDA safety regulations for life-saving medicines, generic drugs, and essential medical equipment.
China “Owns” America’s Generic Drug Supply Chain, U.S. China Commission Says
It’s the most well-known secret on Capitol Hill: China owns the American generic drug supply chain. Basic thyroid or blood pressure medications might finally be put into pill form in an Indian lab and sold under an Indian brand like Cipla. But the organic compounds, or key starting materials, mostly come from China.
JQI Continues to Decline Even Amid Improving Economic Conditions
The U.S. Private Sector Job Quality Index (JQI) is now 84.04, down by 0.49% compared to last month. This continues the multi-month JQI decline trend. Meanwhile, the overall January 2025 Jobs Report from the government’s Bureau of Labor Statistics showed 143,000 jobs added in January.